Best of 2020
Explore the collection to make sure you haven’t missed the most popular and exciting articles!
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Esben Andreas Carlsen et al.
French Endocrine Society Guidance on endocrine side effects of immunotherapy
F Castinetti et al.
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancer
Neil Portman et al.
Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives
Lucieli Ceolin et al.
Androgen hazards with COVID-19
Nima Sharifi and Charles J Ryan
The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
Alastair Davies, Amina Zoubeidi, and Luke A Selth
The treatment of renal hyperparathyroidism
Martin Almquist, Elin Isaksson, and Naomi Clyne
Neuroendocrine neoplasm update: toward universal nomenclature
Guido Rindi and Frediano Inzani
Redifferentiation of radioiodine-refractory thyroid cancers
Camille Buffet et al.
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Halfdan Sorbye, Grace Kong, and Simona Grozinsky-Glasberg
COVID-19 and androgen-targeted therapy for prostate cancer patients
Neil A Bhowmick et al.
Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis
Thi-Van-Trinh Tran et al.